Phase 3b multicenter, randomized, placebo-controlled, double-blind study evaluating immunogenicity and safety of a 3rd and 4th dose of StaphVAX, a bivalent Staphylococcus aureus glycoconjugate vaccine in adults with end-stage renal disease

Trial Profile

Phase 3b multicenter, randomized, placebo-controlled, double-blind study evaluating immunogenicity and safety of a 3rd and 4th dose of StaphVAX, a bivalent Staphylococcus aureus glycoconjugate vaccine in adults with end-stage renal disease

Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Jan 2008

At a glance

  • Drugs Staphylococcus aureus vaccine (Primary)
  • Indications Staphylococcal infections
  • Focus Pharmacodynamics
  • Acronyms SHIELD-2
  • Most Recent Events

    • 03 Jan 2008 Status changed from in progress to discontinued.
    • 21 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top